JP2016533332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533332A5 JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nanoparticle
- self
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881848P | 2013-09-24 | 2013-09-24 | |
| US61/881,848 | 2013-09-24 | ||
| PCT/US2014/057240 WO2015048149A1 (en) | 2013-09-24 | 2014-09-24 | Self-assembled nanoparticle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016533332A JP2016533332A (ja) | 2016-10-27 |
| JP2016533332A5 true JP2016533332A5 (enExample) | 2017-11-02 |
Family
ID=51662365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516958A Ceased JP2016533332A (ja) | 2013-09-24 | 2014-09-24 | 自己集合型ナノ粒子ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150110825A1 (enExample) |
| EP (1) | EP3049107A1 (enExample) |
| JP (1) | JP2016533332A (enExample) |
| CA (1) | CA2925201A1 (enExample) |
| WO (1) | WO2015048149A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| EP3250233A4 (en) * | 2015-01-29 | 2018-07-25 | Agency for Science, Technology and Research | Nanocapsules carrying chikungunya-associated peptides |
| CA3003886A1 (en) * | 2015-11-06 | 2017-05-11 | University Of South Alabama | Novel platform dna vaccine |
| US20180312545A1 (en) * | 2015-11-09 | 2018-11-01 | Curevac Ag | Optimized nucleic acid molecules |
| EP3474893A1 (en) | 2016-06-27 | 2019-05-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類ｂ肝病毒顆粒作為佐劑的疫苗組成物 |
| IL322023A (en) | 2017-04-04 | 2025-09-01 | Univ Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus proteins and their use |
| EP4074734A1 (en) | 2017-08-04 | 2022-10-19 | The Hospital for Sick Children | Nanoparticle platform for antibody and vaccine delivery |
| EP3735269A1 (en) * | 2018-01-06 | 2020-11-11 | Emergex Vaccines Holdings Limited | Mhc class i associated peptides for prevention and treatment of multiple flavi virus |
| AU2019228551B2 (en) | 2018-02-28 | 2025-07-24 | University Of Washington | Self-assembling nanostructure vaccines |
| JP7412001B2 (ja) * | 2018-06-08 | 2024-01-12 | 株式会社モダリス | 改変されたＣａｓ９タンパク質及びその用途 |
| KR102076917B1 (ko) * | 2018-10-25 | 2020-02-13 | 연세대학교 산학협력단 | 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법 |
| US12419949B2 (en) | 2019-07-24 | 2025-09-23 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112439056B (zh) * | 2019-08-28 | 2022-05-31 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用 |
| EP4161570A1 (en) | 2020-06-05 | 2023-04-12 | GlaxoSmithKline Biologicals S.A. | Modified betacoronavirus spike proteins |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN117567652B (zh) * | 2024-01-19 | 2024-05-14 | 北京安百胜生物科技有限公司 | 一种重组呼吸道合胞病毒颗粒抗原 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017853A2 (en) * | 2004-08-11 | 2006-02-16 | Beth Israel Deaconess Medical Center, Inc. | Mutant interleukin-15-containing compositions and suppression of an immune response |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| SI2222710T1 (sl) * | 2007-12-24 | 2016-11-30 | Id Biomedical Corporation Of Quebec | Rekombinatni RSV antigeni |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| DK3275892T3 (da) * | 2011-05-13 | 2020-04-06 | Glaxosmithkline Biologicals Sa | Præfusions-rsv-f-antigener |
| US20130049342A1 (en) * | 2011-08-25 | 2013-02-28 | James Michael Cottrell | Trailer chassis hold down system |
| CN103957891B (zh) * | 2011-09-23 | 2017-01-11 | 美利坚合众国由健康及人类服务部部长代表 | 基于流感血凝素蛋白的新颖疫苗 |
| CA2849471A1 (en) * | 2011-09-30 | 2013-04-04 | Novavax, Inc. | Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| RU2761631C2 (ru) * | 2013-03-13 | 2021-12-13 | Дзе Юнайтед Стэйтс Оф Америка, Эс Репрезентед Бай Дзе Секретэри, Департмент Оф Хелт Энд Хьюман Сервисиз | Белки rsv в предшествующей слиянию конформации и их применение |
-
2014
- 2014-09-24 JP JP2016516958A patent/JP2016533332A/ja not_active Ceased
- 2014-09-24 WO PCT/US2014/057240 patent/WO2015048149A1/en not_active Ceased
- 2014-09-24 US US14/495,640 patent/US20150110825A1/en not_active Abandoned
- 2014-09-24 CA CA2925201A patent/CA2925201A1/en not_active Abandoned
- 2014-09-24 EP EP14781401.6A patent/EP3049107A1/en not_active Withdrawn